Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
RESEARCH TOOLSreports
MoonLake Immunotherapeutics (MLTX) Stock Price & Analysis
257 Followers
MLTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.43 - $64.98
Previous Close$43.64
Volume284.70K
Average Volume (3M)474.31K
Market Cap
$2.73B
Enterprise Value$2.29B
Total Cash (Recent Filing)$495.98M
Total Debt (Recent Filing)$169.42K
Price to Earnings (P/E)-57.2
Beta1.00
Next Earnings
May 10, 2024EPS Estimate
-$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.76
Shares Outstanding63,886,757
10 Day Avg. Volume398,955
30 Day Avg. Volume474,313
Standard Deviation0.22
R-Squared0.08
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)5.66
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-56.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-997.41
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-42.95
Forecast
1Y Price Target
$74.09Price Target Upside70.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
MoonLake Immunotherapeutics News
Ownership Overview
66.52% Insiders
14.66% Mutual Funds
0.46% Other Institutional Investors
18.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MLTX FAQ
What was MoonLake Immunotherapeutics’s price range in the past 12 months?
MoonLake Immunotherapeutics lowest stock price was $18.43 and its highest was $64.98 in the past 12 months.
What is MoonLake Immunotherapeutics’s market cap?
Currently, no data Available
When is MoonLake Immunotherapeutics’s upcoming earnings report date?
MoonLake Immunotherapeutics’s upcoming earnings report date is May 10, 2024 which is in 15 days.
How were MoonLake Immunotherapeutics’s earnings last quarter?
MoonLake Immunotherapeutics released its earnings results on Feb 29, 2024. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.23 by $0.11.
Is MoonLake Immunotherapeutics overvalued?
According to Wall Street analysts MoonLake Immunotherapeutics’s price is currently Undervalued.
Does MoonLake Immunotherapeutics pay dividends?
MoonLake Immunotherapeutics does not currently pay dividends.
What is MoonLake Immunotherapeutics’s EPS estimate?
MoonLake Immunotherapeutics’s EPS estimate is -$0.19.
How many shares outstanding does MoonLake Immunotherapeutics have?
MoonLake Immunotherapeutics has 59,940,530 shares outstanding.
What happened to MoonLake Immunotherapeutics’s price movement after its last earnings report?
MoonLake Immunotherapeutics reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.23. Following the earnings report the stock price went down -15.085%.
Which hedge fund is a major shareholder of MoonLake Immunotherapeutics?
Among the largest hedge funds holding MoonLake Immunotherapeutics’s share is Woodline Partners LP. It holds MoonLake Immunotherapeutics’s shares valued at 7M.
---
MoonLake Immunotherapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$74.09 (70.32% Upside)
$74.09 (70.32% Upside)
Blogger Sentiment
Bullish
MLTX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 132.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
129.20%
12-Months-Change
Fundamentals
Return on Equity
-13.22%
Trailing 12-Months
Asset Growth
585.21%
Trailing 12-Months
Company Description
MoonLake Immunotherapeutics
Helix Acquisition Corp is a blank check company.
---
MLTX Stock 12 Months Forecast
Average Price Target
$74.09
▲(70.32% Upside)
Technical Analysis
Best Analysts Covering MLTX
1 Year
1 Year Success Rate
9/14 ratings generated profit
1 Year Average Return
+140.66%
reiterated a buy rating 2 months ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 64.29% of your transactions generating a profit, with an average return of +140.66% per trade.
---